
Clinical AI Comes of Age | Suchi Saria on the Future of Healthcare
About this episode
Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings.
While much of the recent attention around AI has focused on copilots, chatbots, and administrative workflows, Saria argues that the greatest opportunity lies in helping clinicians make better decisions at the point of care. She explains how Bayesian Health's clinical intelligence platform continuously analyzes multimodal patient data to identify signs of deterioration, sepsis, and other high-risk conditions before they become medical emergencies.
The conversation explores FDA approval, reimbursement, clinician trust, AI governance, hospital workflows, and why healthcare requires a higher standard of evidence than most software categories. Along the way, Saria shares lessons from bringing AI into clinical practice, the future of proactive medicine, and why the next era of healthcare may be defined by continuous intelligence rather than reactive care.
Resources:
Follow Suchi Saria on X: https://x.com/suchisaria
Follow Julie Yoo on X: https://x.com/julieyoo
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Raising Health publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Raising Health

Moderna CEO Stéphane Bancel on the Next Era of mRNA
Raising Health

AI, Healthcare, and 700 Million Patients | Nicolas Abad, Telepatía
Raising Health

Healthcare Will Benefit Most from AI | Julie Yoo on StartUp Health
Raising Health

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
Raising Health